Revascularization in severe left ventricular dysfunction: The role of viability testing

Panithaya Chareonthaitawee, Bernard J. Gersh, Philip A Araoz, Raymond J Gibbons

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.

Original languageEnglish (US)
Pages (from-to)567-574
Number of pages8
JournalJournal of the American College of Cardiology
Volume46
Issue number4
DOIs
StatePublished - Aug 16 2005

Fingerprint

Left Ventricular Dysfunction
Cardiomyopathies
Uncertainty
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Revascularization in severe left ventricular dysfunction : The role of viability testing. / Chareonthaitawee, Panithaya; Gersh, Bernard J.; Araoz, Philip A; Gibbons, Raymond J.

In: Journal of the American College of Cardiology, Vol. 46, No. 4, 16.08.2005, p. 567-574.

Research output: Contribution to journalArticle

@article{39da324cc53344cb8e3d49774a7b2928,
title = "Revascularization in severe left ventricular dysfunction: The role of viability testing",
abstract = "Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.",
author = "Panithaya Chareonthaitawee and Gersh, {Bernard J.} and Araoz, {Philip A} and Gibbons, {Raymond J}",
year = "2005",
month = "8",
day = "16",
doi = "10.1016/j.jacc.2005.03.072",
language = "English (US)",
volume = "46",
pages = "567--574",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Revascularization in severe left ventricular dysfunction

T2 - The role of viability testing

AU - Chareonthaitawee, Panithaya

AU - Gersh, Bernard J.

AU - Araoz, Philip A

AU - Gibbons, Raymond J

PY - 2005/8/16

Y1 - 2005/8/16

N2 - Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.

AB - Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.

UR - http://www.scopus.com/inward/record.url?scp=23644445183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644445183&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2005.03.072

DO - 10.1016/j.jacc.2005.03.072

M3 - Article

C2 - 16098417

AN - SCOPUS:23644445183

VL - 46

SP - 567

EP - 574

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -